These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36446486)

  • 1. Sulfobutylether-β-cyclodextrin: A functional biopolymer for drug delivery applications.
    Pardeshi CV; Kothawade RV; Markad AR; Pardeshi SR; Kulkarni AD; Chaudhari PJ; Longhi MR; Dhas N; Naik JB; Surana SJ; García MC
    Carbohydr Polym; 2023 Feb; 301(Pt B):120347. PubMed ID: 36446486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and
    Al-Heibshy FNS; Başaran E; Öztürk N; Demirel M
    Drug Dev Ind Pharm; 2020 Sep; 46(9):1495-1506. PubMed ID: 32804005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
    Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
    Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications.
    Eid EEM; Almaiman AA; Alshehade SA; Alsalemi W; Kamran S; Suliman FO; Alshawsh MA
    Molecules; 2023 May; 28(10):. PubMed ID: 37241838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of sulfobutylether-β-cyclodextrin/glabridin inclusion complex for promoting bioactivities.
    Wang W; Tang K; Huang C; Liu A
    Arch Pharm (Weinheim); 2024 Aug; 357(8):e2400082. PubMed ID: 38724255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.
    Elmoghayer ME; Saleh NM; Abu Hashim II
    Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of trihexyphenidyl with natural and modified cyclodextrins.
    Maeda H; Tanaka R; Nakayama H
    Springerplus; 2015; 4():218. PubMed ID: 26020020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
    Zhang P; Liu X; Hu W; Bai Y; Zhang L
    Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration.
    Abruzzo A; Croatti V; Zuccheri G; Pasquale Nicoletta F; Sallustio V; Corazza E; Vitali B; Cerchiara T; Luppi B; Bigucci F
    Eur J Pharm Biopharm; 2022 Nov; 180():190-200. PubMed ID: 36210035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the Anti-Leukemic Potential of Thymoquinone/Sulfobutylether-β-cyclodextrin (SBE-β-CD) Inclusion Complexes.
    Eid EEM; Alshehade SA; Almaiman AA; Kamran S; Lee VS; Alshawsh MA
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study.
    Ren L; Wang J; Chen G
    Drug Deliv; 2019 Dec; 26(1):309-317. PubMed ID: 30896265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
    Jarho P; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L; Jing J; Chen G; Miao Y; Wei P
    J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrins.
    Stella VJ; He Q
    Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
    Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
    Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mechanochemical inclusion of triamterene into sulfobutylether-β-cyclodextrin and its improved dissolution behavior.
    Maeda H; Shiobara R; Tanaka M; Kajinami A; Nakayama H
    Drug Dev Ind Pharm; 2021 Apr; 47(4):535-541. PubMed ID: 33185132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfobutylether-β-cyclodextrin.
    Stella VJ; Rajewski RA
    Int J Pharm; 2020 Jun; 583():119396. PubMed ID: 32376442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.